A cancer-antigen called MAGE-A is associated with CTLA-4 inhibitor resistance and is known to suppress autophagy, suggesting that autophagy induction may be used therapeutically as a way to improve the efficacy of CTLA-4 inhibitors in human melanomas (86). This evidence concerns the gene CTLA4 and cancer.